A rice-based oral cholera vaccine induces macaque-specific systemic neutralizing antibodies but does not influence pre-existing intestinal immunity

Journal of Immunology

Volumn 183, Issue 10, 2009, Pages 6538-6544

  Nochi, Tomonori ^a   Yuki, Yoshikazu ^a   Katakai, Yuko ^b   Shibata, Hiroaki ^c   Tokuhara, Daisuke ^a   Mejima, Mio ^a   Kurokawa, Shiho ^a   Takahashi, Yuko ^a   Nakanishi, Ushio ^a   Ono, Fumiko ^b   Mimuro, Hitomi ^a   Sasakawa, Chihiro ^a   Takaiwa, Fumio ^d   Terao, Keiji ^c   Kiyono, Hiroshi ^a  

^a UNIVERSITY OF TOKYO   (Japan)

^b The Corporation for Production and Research of Laboratory Primates   (Japan)

^c NATIONAL INSTITUTE OF BIOMEDICAL INNOVATION   (Japan)

^d NATIONAL INSTITUTE OF AGROBIOLOGICAL SCIENCES   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

CHOLERA TOXIN B SUBUNIT; CHOLERA VACCINE; ENTEROTOXIN; ESCHERICHIA COLI ENTEROTOXIN; IMMUNOGLOBULIN E ANTIBODY; IMMUNOGLOBULIN G ANTIBODY; NEUTRALIZING ANTIBODY; SECRETORY IMMUNOGLOBULIN;

ADOLESCENT; ANIMAL EXPERIMENT; ANTIBODY RESPONSE; ANTIBODY SPECIFICITY; ANTIBODY TITER; ARTICLE; CONTROLLED STUDY; FEMALE; IMMUNE RESPONSE; IMMUNIZATION; MACACA; MUCOSAL IMMUNITY; NONHUMAN; PRIORITY JOURNAL; RICE;

ADMINISTRATION, ORAL; ANIMALS; ANTIBODIES, BACTERIAL; ANTIBODIES, NEUTRALIZING; CHOLERA TOXIN; CHOLERA VACCINES; ENTEROTOXINS; ESCHERICHIA COLI; FEMALE; IMMUNITY, MUCOSAL; IMMUNIZATION; IMMUNOGLOBULIN A; IMMUNOGLOBULIN E; INTESTINES; MACACA FASCICULARIS; MALE; MICE; ORYZA SATIVA; VIBRIO CHOLERAE;

EID: 77952728754     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.0901480     Document Type: Article

References (32)

1. Faruque, S. M., M. J. Albert, and J. J. Mekalanos. 1998. Epidemiology, genetics, and ecology of toxigenic Vibrio cholerae. Microbiol. Mol. Biol. Rev. 62: 1301-1314.
2. Calain, P., J. P. Chaine, E. Johnson, M. L. Hawley, M. J. O'Leary, H. Oshitani, and C. L. Chaignat. 2004. Can oral cholera vaccination play a role in controlling a cholera outbreak? Vaccine 22: 2444-2451.
3. 2007. Weekly epidemiological record. World Health Organization 82: 273-284.
4. Lopez, A. L., J. D. Clemens, J. Deen, and L. Jodar. 2008. Cholera vaccines for the developing world. Hum. Vaccin. 4: 165-169.
5. Clemens, J. D., D. A. Sack, J. R. Harris, J. Chakraborty, M. R. Khan, B. F. Stanton, B. A. Kay, M. U. Khan, M. Yunus, W. Atkinson, et al. 1986. Field trial of oral cholera vaccines in Bangladesh. Lancet 2: 124-127.
6. Sanchez, J. L., B. Vasquez, R. E. Begue, R. Meza, G. Castellares, C. Cabezas, D. M. Watts, A. M. Svennerholm, J. C. Sadoff, and D. N. Taylor. 1994. Protective efficacy of oral whole-cell/recombinant-B-subunit cholera vaccine in Peruvian military recruits. Lancet 344: 1273-1276.
7. Kotloff, K. L., S. S. Wasserman, S. O'Donnell, G. A. Losonsky, S. J. Cryz, and M. M. Levine. 1992. Safety and immunogenicity in North Americans of a single dose of live oral cholera vaccine CVD 103-HgR: results of a randomized, placebo-controlled, double-blind crossover trial. Infect. Immun. 60: 4430-4432.
8. Cryz, S. J., Jr., M. M. Levine, G. Losonsky, J. B. Kaper, and B. Althaus. 1992. Safety and immunogenicity of a booster dose of Vibrio cholerae CVD 103-HgR live oral cholera vaccine in Swiss adults. Infect. Immun. 60: 3916-3917.
9. Trach, D. D., J. D. Clemens, N. T. Ke, H. T. Thuy, N. D. Son, D. G. Canh, P. V. Hang, and M. R. Rao. 1997. Field trial of a locally produced, killed, oral cholera vaccine in Vietnam. Lancet 349: 231-235.
10. Thiem, V. D., J. L. Deen, L. von Seidlein, G. Canh do, D. D. Anh, J. K. Park, M. Ali, M. C. Danovaro-Holliday, N. D. Son, N. T. Hoa, et al. 2006. Long-term effectiveness against cholera of oral killed whole-cell vaccine produced in Vietnam. Vaccine 24: 4297-4303.
11. Kiyono, H., J. Kunisawa, J. R. McGhee, and J. Mestechy. 2008. The mucosal immune system In Fundamental Immunolology, 5th Ed. W. E. Paul, ed., Lippincott Williams and Wilkins, Philadelphia, PA, pp. 983-1030.
12. Kunisawa, J., T. Nochi, and H. Kiyono. 2008. Immunological commonalities and distinctions between airway and digestive immunity. Trends Immunol. 29: 505-513.
13. Holmgren, J., and C. Czerkinsky. 2005. Mucosal immunity and vaccines. Nat. Med. 11: S45-S53.
14. Das, P. 2004. Revolutionary vaccine technology breaks the cold chain. Lancet Infect. Dis. 4: 719.
15. Varmus, H., R. Klausner, E. Zerhouni, T. Acharya, A. S. Daar, and P. A. Singer. 2003. Public health: grand challenges in global health. Science 302: 398-399.
16. Giudice, E. L., and J. D. Campbell. 2006. Needle-free vaccine delivery. Adv. Drug Deliv. Rev. 58: 68-89.
17. Nochi, T., H. Takagi, Y. Yuki, L. Yang, T. Masumura, M. Mejima, U. Nakanishi, A. Matsumura, A. Uozumi, T. Hiroi, et al. 2007. Rice-based mucosal vaccine as a global strategy for cold-chain- and needle-free vaccination. Proc. Natl. Acad. Sci. USA 104: 10986-10991.
18. Yamagata, H., and K. Tanaka. 1986. The site of synthesis and accumulation of rice storage proteins. Plant Cell Physiol. 27: 135-145.
19. Katsube, T., N. Kurisaka, M. Ogawa, N. Maruyama, R. Ohtsuka, S. Utsumi, and F. Takaiwa. 1999. Accumulation of soybean glycinin and its assembly with the glutelins in rice. Plant Physiol. 120: 1063-1074.
20. Yuki, Y., Y. Byun, M. Fujita, W. Izutani, T. Suzuki, S. Udaka, K. Fujihashi, J. R. McGhee, and H. Kiyono. 2001. Production of a recombinant hybrid molecule of cholera toxin-B-subunit and proteolipid-protein-peptide for the treatment of experimental encephalomyelitis. Biotechnol. Bioeng. 74: 62-69.
21. Dallas, W. S., and S. Falkow. 1980. Amino acid sequence homology between cholera toxin and Escherichia coli heat-labile toxin. Nature 288: 499-501.
22. Arakawa, T., D. K. Chang, W. H. Langridge. 1998. Efficacy of a food plant-based oral cholera toxin B subunit vaccine. Nat. Biotech. 16: 292-297.
23. Kubota, M., C. J. Miller, K. Imaoka, S. Kawabata, K. Fujihashi, J. R. McGhee, and H. Kiyono. 1997. Oral immunization with simian immunodeficiency virus p55gag and cholera toxin elicits both mucosal IgA and systemic IgG immune responses in nonhuman primates. J. Immunol. 158: 5321-5329.
24. Macpherson, A. J., and T. Uhr. 2004. Induction of protective IgA by intestinal dendritic cells carrying commensal bacteria. Science 303: 1662-1665.
25. Rescigno, M., M. Urbano, B. Valzasina, M. Francolini, G. Rotta, R. Bonasio, F. Granucci, J. P. Kraehenbuhl, and P. Ricciardi-Castagnoli. 2001. Dendritic cells express tight junction proteins and penetrate gut epithelial monolayers to sample bacteria. Nat. Immunol. 2: 361-367.
26. Niess, J. H., S. Brand, X. Gu, L. Landsman, S. Jung, B. A. McCormick, J. M. Vyas, M. Boes, H. L. Ploegh, J. G. Fox, et al. 2005. CX3CR1-mediated dendritic cell access to the intestinal lumen and bacterial clearance. Science 307: 254-258.
27. Jang, M. H., M. N. Kweon, K. Iwatani, M. Yamamoto, K. Terahara, C. Sasakawa, T. Suzuki, T. Nochi, Y. Yokota, P. D. Rennert, et al. 2004. Intestinal villous M cells: an antigen entry site in the mucosal epithelium. Proc. Natl. Acad. Sci. USA 101: 6110-6115.
28. Macpherson, A. J., K. D. McCoy, F. E. Johansen, and P. Brandtzaeg. 2008. The immune geography of IgA induction and function. Mucosal. Immunol. 1: 11-22.
29. Sait, L., M. Galic, R. A. Strugnell, and P. H. Janssen. 2003. Secretory antibodies do not affect the composition of the bacterial microbiota in the terminal ileum of 10-week-old mice. Appl. Environ. Microbiol. 69: 2100-2109.
30. Wijburg, O. L., T. K. Uren, K. Simpfendorfer, F. E. Johansen, P. Brandtzaeg, and R. A. Strugnell. 2006. Innate secretory antibodies protect against natural Salmonella typhimurium infection. J. Exp. Med. 203: 21-26.
31. Ivanoff, B., J. L. Tayot, O. Creach, and R. Fontanges. 1978. Experimental cholera in monkeys. Bull. Soc. Pathol. Exot. Filiales 71: 240-248.
32. Clemens, J. D., D. A. Sack, J. R. Harris, J. Chakraborty, M. R. Khan, B. F. Stanton, M. Ali, F. Ahmed, M. Yunus, B. A. Kay, et al. 1988. Impact of B subunit killed whole-cell and killed whole-cell-only oral vaccines against cholera upon treated diarrhoeal illness and mortality in an area endemic for cholera. Lancet 1: 1375-1379.